Report: Telemedicine spending to approach $3.6B annually by 2014

The market for telemedicine devices and services will generate nearly $3.6 billion in annual revenue within the next five years, with mobile services companies taking a sizeable chunk of that business, according to a report from market research firm Pike & Fischer (P&F).

The need to control costs, along with the development and expansion of faster wireless broadband networks, smartphones and data compression solutions, will drive the market growth, P&F said. Wireless applications, devices and services will account for more than 70 percent of the total market spending within five years, the Silver Spring, Md.-based company projected in the report.

AT&T will have the largest presence in this market, followed closely by Verizon and Sprint Nextel, predicted Tim Deal, a senior analyst in P&F's broadband advisory services group. He also believes that smaller software and device manufacturers will quickly find themselves targeted for acquisition.

Driving that spending is the economic stimulus legislation that President Barack Obama signed earlier this year. The initiative included $20 billion for health IT, with a specific focus on EMRs and telemedicine. P&F forecast that at least 25 percent of the $20 billion in stimulus funds earmarked for health IT will be applied toward broadband-enabled telemedicine services, such as remote patient monitoring and mobile access to medical records, and consumer applications, such as interactive fitness guides and mobile health-related videos.

“These estimates will climb if the Obama administration’s proposed healthcare reform plan passes,” said Deal. “The proposed healthcare reform includes an investment of $50 billion over five years to promote health IT.”

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.